Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 122 | 342 | 1,245 | 1,976 | 2,527 |
| Receivables | 89 | 81 | 144 | 118 | 79 |
| Inventories | 130 | 121 | 131 | 135 | 163 |
| Other current assets | 28 | 31 | 55 | 21 | 42 |
| TOTAL | $369 | $576 | $1,575 | $2,250 | $2,811 |
| Non-Current Assets | |||||
| PPE Net | 54 | 57 | 57 | 60 | 60 |
| Intangibles | 1,143 | 1,106 | 1,091 | 1,087 | 1,109 |
| TOTAL | $1,197 | $1,163 | $1,148 | $1,147 | $1,169 |
| Total Assets | $1,566 | $1,739 | $2,723 | $3,397 | $3,980 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 500 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 205 | 191 | 498 | 224 | 124 |
| Accrued Expenses | 595 | 349 | N/A | 435 | N/A |
| TOTAL | $1,300 | $540 | $832 | $659 | $386 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,300 | $540 | $832 | $659 | $386 |
| Shareholders' Equity | |||||
| Common Shares | 0 | 0 | 0 | 17,683 | 0 |
| Retained earnings | -22,641 | -21,645 | -20,943 | -20,053 | -19,164 |
| Other shareholders' equity | 1,394 | 1,344 | 1,373 | 1,373 | 1,426 |
| TOTAL | $266 | $1,199 | $1,891 | $2,738 | $3,594 |
| Total Liabilities And Equity | $1,566 | $1,739 | $2,723 | $3,397 | $3,980 |